Latest Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Peter G Clifford, EVP & CFO of Fortune Brands Innovations, Inc., reported multiple transactions in common stock on September 28, 2026.
NYSE
Tom W Bolin, VICE PRESIDENT of Dillard'S, Inc., received 12 shares of common stock on September 28, 2026.
NASDAQ
John Ternus, CEO and a Director of Apple Inc., reported multiple transactions in common stock on September 27, 2026.
NYSE
William T. Dillard Iii, SENIOR VICE PRESIDENT and a Director of Dillard'S, Inc., received 17 shares of common stock on September 28, 2026.
NYSE
Annemarie Jazic, VICE PRESIDENT of Dillard'S, Inc., received 8 shares of common stock on September 28, 2026.
NYSE
Alex Dillard, PRESIDENT, a Director and 10% owner of Dillard'S, Inc., received 17 shares of common stock on September 28, 2026.
NASDAQ
Sanjiv Das, President of Pagaya Technologies Ltd., sold 14,300 shares of common stock on September 25, 2026 for $17.04 per share.
NASDAQ
Jonathan Dobres, Chief Financial Officer of Pagaya Technologies Ltd., sold 590 shares of common stock on September 25, 2026 for $17.04 per share.
NASDAQ
Hamish Mclennan, a Director of Light & Wonder, Inc., purchased 5,750 shares of common stock on March 10, 2022.
NYSE
Denise Dillard Mahaffy, SENIOR VICE PRESIDENT and a Director of Dillard'S, Inc., received 11 shares of common stock on September 28, 2026.
NASDAQ
Timothy D Cook, Executive Chair and a Director of Apple Inc., reported multiple transactions in common stock on September 27, 2026.
NYSE
William T Dillard Ii, CEO, CHAIRMAN OF BOARD, a Director and 10% owner of Dillard'S, Inc., received 17 shares of common stock on September 28, 2026.
NASDAQ
Teresa Brophy Bair, Chief Legal Officer of Kura Oncology, Inc., sold 8,442 shares of common stock on September 28, 2026 for $10.50 per share.
NASDAQ
Kathleen Ford, Chief Operating Officer of Kura Oncology, Inc., sold 10,574 shares of common stock on September 28, 2026.
NASDAQ
Mollie Leoni, Chief Medical Officer of Kura Oncology, Inc., sold 41,250 shares of common stock on September 28, 2026.
NASDAQ
Thomas James Doyle, SVP, Finance & Accounting of Kura Oncology, Inc., sold 4,607 shares of common stock on September 28, 2026 for $10.50 per share.
NASDAQ
Brian T. Powl, Chief Commercial Officer of Kura Oncology, Inc., sold 32,450 shares of common stock on September 28, 2026.
NYSE
Mike Dillard, EXECUTIVE VICE PRESIDENT, a Director and 10% owner of Dillard'S, Inc., received 12 shares of common stock on September 28, 2026.
NYSE
Dean L. Worley, VP/GENERAL COUNSEL & SECRETARY of Dillard'S, Inc., received 9 shares of common stock on September 28, 2026.
NYSE
Phillip R. Watts, SENIOR VICE PRESIDENT of Dillard'S, Inc., received 10 shares of common stock on September 28, 2026.
NYSE
James D Stockman, VICE PRESIDENT of Dillard'S, Inc., received 13 shares of common stock on September 28, 2026.
NYSE
Kurtis Joseph Binder, CHIEF FINANCIAL OFFICER of Arlo Technologies, Inc., sold 96,569 shares of common stock on September 28, 2026.
NYSE
Brant Musgrave, CORPORATE VP STORES of Dillard'S, Inc., received 8 shares of common stock on September 28, 2026.
NYSE
Irial Finan, a Director of Fortune Brands Innovations, Inc., received 943 shares of common stock on September 28, 2026.
NYSE
Denise Alexandra Lucie, VICE PRESIDENT of Dillard'S, Inc., received 8 shares of common stock on September 28, 2026.
NYSE
Mike Litchford, VICE PRESIDENT of Dillard'S, Inc., received 14 shares of common stock on September 28, 2026.
NYSE
Drue Matheny, EXECUTIVE VICE PRESIDENT and a Director of Dillard'S, Inc., received 12 shares of common stock on September 28, 2026.
NYSE
Chris B. Johnson, SENIOR VICE PRESIDENT of Dillard'S, Inc., reported multiple transactions in common stock on September 28, 2026.
NYSE
Julie M. Williams, SVP/Cont. Improvement and Opt. of Southwest Gas Holdings, Inc., sold 2,500 shares of common stock on September 28, 2026 for $81.81 per share.
NYSE
Jeffrey R. Leitzell, EVP & COO of Eog Resources Inc, sold 9,039 shares of common stock on September 25, 2026 for $140.61 per share.